REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bukk-Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: BUKK-PHARMA Gyogyszertar Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Bukk-Pharma Kft. is an enterprise in Hungary, with the main office in Eger. It operates in the Pharmacies and Drug Stores industry. It was incorporated on June 27, 2008. 6 (2024) employees currently work for Bukk-Pharma Kft.. The company’s latest financial report indicates a net sales revenue increase of 2.52% in 2023. Its’ total assets recorded a growth of 26.01%. In 2023, Bukk-Pharma Kft.’s net profit margin increased by 1.6%.

Headquarters
Kallomalom utca 88-90.
Eger; Heves; Postal Code: 3300

Contact Details: Purchase the Bukk-Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Bukk-Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Bukk-Pharma Kft. report to view the information.
Registered Capital:
Purchase the Bukk-Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Bukk-Pharma Kft. report to view the information.
Incorporation Date:
June 27, 2008
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Bukk-Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
2.52%▲
Total operating revenue
2.67%▲
Operating profit (EBIT)
90.17%▲
EBITDA
97.09%▲
Net Profit (Loss) for the Period
105.93%▲
Total assets
26.01%▲
Total equity
34.28%▲
Operating Profit Margin (ROS)
1.83%▲
Net Profit Margin
1.6%▲
Return on Equity (ROE)
8.88%▲
Quick Ratio
0.59%▲
Cash Ratio
0.64%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo